Sort
23,748 grants matching “melanoma”
Administrative and Statistics Core
$317,203Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA
Genetic Expression of Lentigo Malignant Melanoma, Proj. 2 - UCSF consortium
$317,133Boris C Bastian · Wistar Institute · P01 · FY2006 · CA
IMCPL / Flow Cytometry
$317,124Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Catheter-Based Ultrasound Hyperthermia System for 3D-Targeted Thermal Therapy
$317,109Chris John Diederich · University Of California, San Francisco · R01 · FY2007 · CA
Regulation of Melanocyte Differentiation by SWI/SNF Chromatin Remodeling Enzymes
$317,097Ivana L De La Serna · University Of Toledo Health Sci Campus · R01 · FY2014 · AR
Mitochondrial lateral transfer during metastasis
$317,048Minna Roh · University Of Utah · R37 · FY2024 · CA
Mechanistic studies of gamma-glutamyl transpeptidase inhibition: A novel approach to modulating serum levels of cysteine
$317,035Marie H Hanigan · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · GM
Bone cancer and skeletal pain
$317,029University Of Minnesota Twin Cities · R01 · FY2002 · CA
Analysis of cap-dependent translational repression by microRNAs in oncogensis
$317,009Carl D Novina · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Melanoma Pathogenesis
$317,000Dartmouth College · R01 · FY2004 · CA
Role of SIRT1 in melanocyte biology and melanocyte transformation
$316,997Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2014 · CA
Cyclin D1 function in tumorigenesis and differentiation
$316,994Mark E Ewen · Tufts Medical Center · R01 · FY2010 · CA
Photonic Nanosonophores for Functional and Structural Imaging
$316,880Raoul Kopelman · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
TR&D2: Nanoimmunomaterials for Immune Engineering
$316,840Jordan Green · Johns Hopkins University · P41 · FY2020 · EB
TR&D2: Nanoimmunomaterials for Immune Engineering
$316,840Jordan Green · Johns Hopkins University · P41 · FY2019 · EB
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention
$316,789Mohammad Athar · University Of Alabama At Birmingham · R01 · FY2007 · ES
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
$316,761Jonathan P Schneck · Johns Hopkins University · P41 · FY2023 · EB
A Phase II Trial for Neutron Capture Therapy in Melanoma
$316,730Beth Israel Deaconess Medical Center · R01 · FY2003 · CA
A Phase II Trial for Neutron Capture Therapy in Melanoma
$316,730Beth Israel Deaconess Medical Center · R01 · FY2002 · CA
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$316,709University Of California Davis · U10 · FY2001 · CA
Elucidating the Regulation and Function of the NF1 tumor suppressor
$316,635Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2016 · CA
Elucidating the Regulation and Function of the NF1 tumor suppressor
$316,635Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2018 · CA
Elucidating the Regulation and Function of the NF1 tumor suppressor
$316,635Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2020 · CA
Elucidating the Regulation and Function of the NF1 tumor suppressor
$316,635Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2017 · CA
Novel TYRO3 inhibitors for treatment of cancer
$316,619Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA